GNH USA

Europe — EMA

Otobrol (Ondansetron)

Ondansetron, the active ingredient in Otobrol, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and…

Request sourcing

1
Pack/s

What is Ondansetron?

Ondansetron, the active ingredient in Otobrol, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. GNH USA supplies Otobrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otobrol as a licensed, GDP‑compliant international pharmaceutical ...

What is Ondansetron used for?

Ondond...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ondansetron
Route
Oral Use
Manufacturer
Farmoz - Sociedade Técnico Medicinal, S.A.
Origin
EU

Related products